Sun Pharmaceutical Industries, an Indian specialty pharmaceutical company, has reported that the FDA has granted its subsidiary an approval for its abbreviated new drug application to market generic Roxicodone, oxycodone hydrochloride tablets.
Subscribe to our email newsletter
According to Sun Pharma, these oxycodone tablets are therapeutically equivalent to Roxicodone tablets from Xanodyne Pharmaceuticals and are available in three strengths: 5mg, 15mg and 30mg.
Oxycodone is a narcotic painkiller used in the treatment of moderate to severe pain. This product is expected to reach the market shortly.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.